Work

Spanish real-life practice confirms zanubrutinib as a safe and effective option in relapsed or refractory marginal zone lymphoma: Results of a cohort of 118 patients on behalf of GELTAMO.

Year: 2025
Type: conference-abstract
Source: Blood
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W4417009752
Cites:
Cited by:
Related to: